Hbk Investments L P Biogen Inc. Transaction History

Hbk Investments L P

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $5.64 Million - $7.79 Million	25,614 Added 692.83%	29,311 $8.7 Million
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $8.44 Million - $9.31 Million	-38,495 Reduced 91.24%	3,697 $865,000
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $3.86 Million - $6.04 Million	17,824 Added 73.15%	42,192 $9.97 Million
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $6.09 Million - $7.72 Million	-21,875 Reduced 47.3%	24,368 $7.33 Million
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $27 Million - $35.3 Million	-91,930 Reduced 66.53%	46,243 $16.3 Million
Q2 2018 Aug 14, 2018	SELL	$257.52 - $306.91 $10.9 Million - $13 Million	-42,357 Reduced 23.46%	138,173 $40.1 Million
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $39.5 Million - $55.9 Million	151,830 Added 529.02%	180,530 $49.4 Million
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $8.83 Million - $9.89 Million	28,700	28,700 $9.14 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Hbk Investments L P, based on Form 13F filings with the SEC.

Stay updated on Hbk Investments L P with notifications on news.